Brief: Vaccinex Inc Announces Presentation At The 2022 Alzheimer’s Association International
29/07/2022 12:37
July 29 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX, INC. ANNOUNCES PRESENTATION AT THE 2022
ALZHEIMER’S
ASSOCIATION INTERNATIONAL CONFERENCE UPDATING THE SIGNAL-AD
STUDY OF PEPINEMAB IN PATIENTS WITH ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNX9Jbc9X
Further company coverage: VCNX.O
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease